EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Age and Health Status Benefits Following Initiation of Atrial Fibrillation‐Specific Treatments

Ryo Nakamaru iD, Nobuhiro Ikemura iD, Shun Kohsaka iD, Takehiro Kimura iD, Yoshinori Katsumata iD, Takahiko Nishiyama iD, Ikuko Ueda iD, Kojiro Tanimoto iD, Koji Negishi, Seiji Takatsuki iD, John A Spertus iD, Masaki Ieda iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.041512 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Ryo Nakamaru und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine Kyorin University School of Medicine Tokyo Japan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Quality of Life, Health Status, Anti-Arrhythmia Agents. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrillation (AF) is managed with various strategies, including rate and rhythm control, to improve patients' health status. Although its incidence increases with age, how age affects health status improvements following AF treatment remains unknown.

Methods

Using data from a multicenter registry for outpatients with newly recognized AF, baseline and 1‐year health status was assessed with the Atrial Fibrillation Effect on Quality‐of‐life quesTionnaire (AFEQT). The associations between age and 1‐year changes in AFEQT‐overall summary and subdomain scores with rate or rhythm control strategies were estimated using generalized additive models. To address nonlinear relationships, we developed multivariable linear regression models with age range categories (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationQuality of LifeHealth StatusAnti-Arrhythmia AgentsHumansFemaleMaleAgedAge FactorsMiddle AgedRegistriesTreatment OutcomeAged, 80 and overHeart RateTime FactorsSurveys and Questionnaires

Stichwörter der Autor:innen

AFEQTageatrial fibrillationhealth‐related quality of life

Substanzen

Anti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine Kyorin University School of Medicine Tokyo Japan.
  • Department of Cardiology Keio University School of Medicine Tokyo Japan.
  • Saint Luke's Mid America Heart Institute Kansas City MO USA.
  • University of Missouri-Kansas City Healthcare Institute for Innovations in Quality Kansas City MO USA.
  • Department of Cardiology National Hospital Organization, Tokyo Medical Center Tokyo Japan.
  • Department of Cardiology Yokohama Municipal Citizen's Hospital Yokohama Japan.

ORCID-Profile: Ryo Nakamaru, Nobuhiro Ikemura, Shun Kohsaka, Takehiro Kimura, Yoshinori Katsumata, Takahiko Nishiyama, Ikuko Ueda, Kojiro Tanimoto, Seiji Takatsuki, John A Spertus, Masaki Ieda

Zitieren

APA

Nakamaru, R., Ikemura, N., Kohsaka, S., Kimura, T., Katsumata, Y., Nishiyama, T., Ueda, I., Tanimoto, K., Negishi, K., Takatsuki, S., Spertus, J. A., & Ieda, M. (2025). Age and Health Status Benefits Following Initiation of Atrial Fibrillation‐Specific Treatments. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.041512

Vancouver

Nakamaru R, Ikemura N, Kohsaka S, Kimura T, Katsumata Y, Nishiyama T, et al. Age and Health Status Benefits Following Initiation of Atrial Fibrillation‐Specific Treatments. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.041512

BibTeX
@article{Nakamaru2025,
  author = {Nakamaru, Ryo and Ikemura, Nobuhiro and Kohsaka, Shun and Kimura, Takehiro and Katsumata, Yoshinori and Nishiyama, Takahiko and Ueda, Ikuko and Tanimoto, Kojiro and Negishi, Koji and Takatsuki, Seiji and Spertus, John A and Ieda, Masaki},
  title = {Age and Health Status Benefits Following Initiation of Atrial Fibrillation‐Specific Treatments},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.041512}
}
Kostenlos starten →